ID   ST17A_HUMAN             Reviewed;         414 AA.
AC   Q9UEE5; A4D1V6; Q8IVC8;
DT   20-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 2.
DT   12-OCT-2022, entry version 180.
DE   RecName: Full=Serine/threonine-protein kinase 17A;
DE            EC=2.7.11.1;
DE   AltName: Full=DAP kinase-related apoptosis-inducing protein kinase 1;
GN   Name=STK17A; Synonyms=DRAK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION,
RP   AUTOPHOSPHORYLATION, TISSUE SPECIFICITY, MUTAGENESIS OF LYS-90, AND VARIANT
RP   GLU-362.
RC   TISSUE=Liver, and Placenta;
RX   PubMed=9786912; DOI=10.1074/jbc.273.44.29066;
RA   Sanjo H., Kawai T., Akira S.;
RT   "DRAKs, novel serine/threonine kinases related to death-associated protein
RT   kinase that trigger apoptosis.";
RL   J. Biol. Chem. 273:29066-29071(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT GLU-362.
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S., Kwasnicka D.,
RA   Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z., Lu F., Zeesman S.,
RA   Nowaczyk M.J., Teshima I., Chitayat D., Shuman C., Weksberg R.,
RA   Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N.,
RA   Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F., Belloni E.,
RA   Shaffer L.G., Pober B., Morton C.C., Gusella J.F., Bruns G.A.P., Korf B.R.,
RA   Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T.,
RA   Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M., Gripp K.W.,
RA   Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H., Teebi A.,
RA   Minassian B.A., Kere J., Armengol L., Pujana M.A., Estivill X.,
RA   Wilson M.D., Koop B.F., Tosi S., Moore G.E., Boright A.P., Zlotorynski E.,
RA   Kerem B., Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J.,
RA   Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT GLU-362.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLU-362.
RC   TISSUE=Colon, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INDUCTION.
RX   PubMed=15940259; DOI=10.1038/sj.onc.1208755;
RA   Kerley-Hamilton J.S., Pike A.M., Li N., DiRenzo J., Spinella M.J.;
RT   "A p53-dominant transcriptional response to cisplatin in testicular germ
RT   cell tumor-derived human embryonal carcinoma.";
RL   Oncogene 24:6090-6100(2005).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-9, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [9]
RP   ACTIVITY REGULATION.
RX   PubMed=21802008; DOI=10.1016/j.chembiol.2011.05.010;
RA   Miduturu C.V., Deng X., Kwiatkowski N., Yang W., Brault L.,
RA   Filippakopoulos P., Chung E., Yang Q., Schwaller J., Knapp S., King R.W.,
RA   Lee J.D., Herrgard S., Zarrinkar P., Gray N.S.;
RT   "High-throughput kinase profiling: a more efficient approach toward the
RT   discovery of new kinase inhibitors.";
RL   Chem. Biol. 18:868-879(2011).
RN   [10]
RP   FUNCTION, AND INDUCTION.
RX   PubMed=21489989; DOI=10.1074/jbc.m111.218040;
RA   Mao P., Hever M.P., Niemaszyk L.M., Haghkerdar J.M., Yanco E.G., Desai D.,
RA   Beyrouthy M.J., Kerley-Hamilton J.S., Freemantle S.J., Spinella M.J.;
RT   "Serine/threonine kinase 17A is a novel p53 target gene and modulator of
RT   cisplatin toxicity and reactive oxygen species in testicular cancer
RT   cells.";
RL   J. Biol. Chem. 286:19381-19391(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13 AND SER-28, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   VARIANTS [LARGE SCALE ANALYSIS] ASP-126; THR-167; GLN-286 AND GLU-362.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Acts as a positive regulator of apoptosis. Also acts as a
CC       regulator of cellular reactive oxygen species.
CC       {ECO:0000269|PubMed:21489989, ECO:0000269|PubMed:9786912}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- ACTIVITY REGULATION: Inhibited by thiazolidinedione-type compounds:
CC       inhibited by furan- and pyridone- thiazolidinediones.
CC       {ECO:0000269|PubMed:21802008}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:9786912}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in placenta. Lower levels in
CC       heart, lung, skeletal muscle, kidney and pancreas.
CC       {ECO:0000269|PubMed:9786912}.
CC   -!- INDUCTION: Directly regulated by p53/TP53: induced following cisplatin
CC       treatment in a p53/TP53-dependent manner. p53/TP53 activates expression
CC       by directly binding to its regulatory regions.
CC       {ECO:0000269|PubMed:15940259, ECO:0000269|PubMed:21489989}.
CC   -!- PTM: Autophosphorylated.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. DAP kinase subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB011420; BAA34126.1; -; mRNA.
DR   EMBL; CH236951; EAL24008.1; -; Genomic_DNA.
DR   EMBL; AC005189; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC011738; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093645; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471073; EAW94162.1; -; Genomic_DNA.
DR   EMBL; BC023508; AAH23508.2; -; mRNA.
DR   EMBL; BC047696; AAH47696.1; -; mRNA.
DR   CCDS; CCDS5470.1; -.
DR   RefSeq; NP_004751.2; NM_004760.2.
DR   PDB; 7QUE; X-ray; 2.40 A; A/B=50-322.
DR   PDB; 7QUF; X-ray; 2.60 A; A/B=50-322.
DR   PDBsum; 7QUE; -.
DR   PDBsum; 7QUF; -.
DR   AlphaFoldDB; Q9UEE5; -.
DR   SMR; Q9UEE5; -.
DR   BioGRID; 114685; 6.
DR   IntAct; Q9UEE5; 4.
DR   STRING; 9606.ENSP00000319192; -.
DR   BindingDB; Q9UEE5; -.
DR   ChEMBL; CHEMBL4525; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; Q9UEE5; -.
DR   GuidetoPHARMACOLOGY; 2214; -.
DR   iPTMnet; Q9UEE5; -.
DR   PhosphoSitePlus; Q9UEE5; -.
DR   BioMuta; STK17A; -.
DR   DMDM; 317373279; -.
DR   EPD; Q9UEE5; -.
DR   jPOST; Q9UEE5; -.
DR   MassIVE; Q9UEE5; -.
DR   MaxQB; Q9UEE5; -.
DR   PaxDb; Q9UEE5; -.
DR   PeptideAtlas; Q9UEE5; -.
DR   PRIDE; Q9UEE5; -.
DR   ProteomicsDB; 84141; -.
DR   Antibodypedia; 13168; 342 antibodies from 40 providers.
DR   DNASU; 9263; -.
DR   Ensembl; ENST00000319357.6; ENSP00000319192.5; ENSG00000164543.7.
DR   Ensembl; ENST00000648544.1; ENSP00000497301.1; ENSG00000164543.7.
DR   GeneID; 9263; -.
DR   KEGG; hsa:9263; -.
DR   MANE-Select; ENST00000319357.6; ENSP00000319192.5; NM_004760.3; NP_004751.2.
DR   UCSC; uc003tih.4; human.
DR   CTD; 9263; -.
DR   DisGeNET; 9263; -.
DR   GeneCards; STK17A; -.
DR   HGNC; HGNC:11395; STK17A.
DR   HPA; ENSG00000164543; Low tissue specificity.
DR   MIM; 604726; gene.
DR   neXtProt; NX_Q9UEE5; -.
DR   OpenTargets; ENSG00000164543; -.
DR   PharmGKB; PA36203; -.
DR   VEuPathDB; HostDB:ENSG00000164543; -.
DR   eggNOG; KOG0032; Eukaryota.
DR   GeneTree; ENSGT00940000154014; -.
DR   HOGENOM; CLU_000288_63_0_1; -.
DR   InParanoid; Q9UEE5; -.
DR   OMA; ACRAWNK; -.
DR   OrthoDB; 1156450at2759; -.
DR   PhylomeDB; Q9UEE5; -.
DR   TreeFam; TF314166; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   PathwayCommons; Q9UEE5; -.
DR   SignaLink; Q9UEE5; -.
DR   SIGNOR; Q9UEE5; -.
DR   BioGRID-ORCS; 9263; 14 hits in 1111 CRISPR screens.
DR   ChiTaRS; STK17A; human.
DR   GenomeRNAi; 9263; -.
DR   Pharos; Q9UEE5; Tchem.
DR   PRO; PR:Q9UEE5; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; Q9UEE5; protein.
DR   Bgee; ENSG00000164543; Expressed in lymph node and 194 other tissues.
DR   Genevisible; Q9UEE5; HS.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:2000271; P:positive regulation of fibroblast apoptotic process; IMP:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:2000377; P:regulation of reactive oxygen species metabolic process; IMP:UniProtKB.
DR   CDD; cd14197; STKc_DRAK1; 1.
DR   InterPro; IPR042704; DRAK1_STKc.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Apoptosis; ATP-binding; Kinase; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN           1..414
FT                   /note="Serine/threonine-protein kinase 17A"
FT                   /id="PRO_0000086704"
FT   DOMAIN          61..321
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..40
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          342..363
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        186
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         67..75
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         90
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   MOD_RES         9
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19369195"
FT   MOD_RES         13
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         28
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VARIANT         126
FT                   /note="E -> D (in dbSNP:rs56286238)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041145"
FT   VARIANT         167
FT                   /note="M -> T (in dbSNP:rs35940029)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041146"
FT   VARIANT         286
FT                   /note="E -> Q (in dbSNP:rs3779062)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_032823"
FT   VARIANT         362
FT                   /note="K -> E (in dbSNP:rs1044141)"
FT                   /evidence="ECO:0000269|PubMed:12690205,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846,
FT                   ECO:0000269|PubMed:9786912, ECO:0000269|Ref.4"
FT                   /id="VAR_019991"
FT   MUTAGEN         90
FT                   /note="K->A: Loss of activity and of apoptotic function."
FT                   /evidence="ECO:0000269|PubMed:9786912"
FT   HELIX           55..57
FT                   /evidence="ECO:0007829|PDB:7QUE"
FT   STRAND          59..61
FT                   /evidence="ECO:0007829|PDB:7QUE"
FT   STRAND          63..65
FT                   /evidence="ECO:0007829|PDB:7QUF"
FT   STRAND          67..69
FT                   /evidence="ECO:0007829|PDB:7QUE"
FT   STRAND          71..80
FT                   /evidence="ECO:0007829|PDB:7QUE"
FT   TURN            81..83
FT                   /evidence="ECO:0007829|PDB:7QUE"
FT   STRAND          86..96
FT                   /evidence="ECO:0007829|PDB:7QUE"
FT   HELIX           102..114
FT                   /evidence="ECO:0007829|PDB:7QUE"
FT   TURN            115..117
FT                   /evidence="ECO:0007829|PDB:7QUE"
FT   STRAND          124..129
FT                   /evidence="ECO:0007829|PDB:7QUE"
FT   STRAND          131..139
FT                   /evidence="ECO:0007829|PDB:7QUE"
FT   HELIX           148..153
FT                   /evidence="ECO:0007829|PDB:7QUE"
FT   HELIX           160..179
FT                   /evidence="ECO:0007829|PDB:7QUE"
FT   HELIX           189..191
FT                   /evidence="ECO:0007829|PDB:7QUE"
FT   STRAND          192..195
FT                   /evidence="ECO:0007829|PDB:7QUE"
FT   TURN            197..200
FT                   /evidence="ECO:0007829|PDB:7QUE"
FT   STRAND          203..205
FT                   /evidence="ECO:0007829|PDB:7QUE"
FT   HELIX           217..222
FT                   /evidence="ECO:0007829|PDB:7QUE"
FT   HELIX           227..229
FT                   /evidence="ECO:0007829|PDB:7QUE"
FT   HELIX           232..236
FT                   /evidence="ECO:0007829|PDB:7QUE"
FT   HELIX           242..258
FT                   /evidence="ECO:0007829|PDB:7QUE"
FT   HELIX           268..277
FT                   /evidence="ECO:0007829|PDB:7QUE"
FT   HELIX           285..287
FT                   /evidence="ECO:0007829|PDB:7QUE"
FT   HELIX           292..301
FT                   /evidence="ECO:0007829|PDB:7QUE"
FT   HELIX           306..308
FT                   /evidence="ECO:0007829|PDB:7QUE"
FT   HELIX           312..317
FT                   /evidence="ECO:0007829|PDB:7QUE"
FT   HELIX           319..321
FT                   /evidence="ECO:0007829|PDB:7QUE"
SQ   SEQUENCE   414 AA;  46558 MW;  E2140290492C2A10 CRC64;
     MIPLEKPGSG GSSPGATSGS GRAGRGLSGP CRPPPPPQAR GLLTEIRAVV RTEPFQDGYS
     LCPGRELGRG KFAVVRKCIK KDSGKEFAAK FMRKRRKGQD CRMEIIHEIA VLELAQDNPW
     VINLHEVYET ASEMILVLEY AAGGEIFDQC VADREEAFKE KDVQRLMRQI LEGVHFLHTR
     DVVHLDLKPQ NILLTSESPL GDIKIVDFGL SRILKNSEEL REIMGTPEYV APEILSYDPI
     SMATDMWSIG VLTYVMLTGI SPFLGNDKQE TFLNISQMNL SYSEEEFDVL SESAVDFIRT
     LLVKKPEDRA TAEECLKHPW LTQSSIQEPS FRMEKALEEA NALQEGHSVP EINSDTDKSE
     TKESIVTEEL IVVTSYTLGQ CRQSEKEKME QKAISKRFKF EEPLLQEIPG EFIY
//
